Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Int J Obes (Lond) ; 46(3): 661-668, 2022 03.
Artículo en Inglés | MEDLINE | ID: mdl-34974543

RESUMEN

BACKGROUND: Patients with obesity have an increased risk for adverse COVID-19 outcomes. Body mass index (BMI) does not acknowledge the health burden associated this disease. The performance of the Edmonton Obesity Staging System (EOSS), a clinical classification tool that assesses obesity-related comorbidity, is compared with BMI, with respect to adverse COVID-19 outcomes. METHODS: 1071 patients were evaluated in 11 COVID-19 hospitals in Mexico. Patients were classified into EOSS stages. Adjusted risk factors for COVID-19 outcomes were calculated and survival analysis for mechanical ventilation and death was carried out according to EOSS stage and BMI category. RESULTS: The risk for intubation was higher in patients with EOSS stages 2 and 4 (HR 1.42, 95% CI 1.02-1.97 and 2.78, 95% CI 1.83-4.24), and in patients with BMI classes II and III (HR 1.71, 95% CI 1.06-2.74, and 2.62, 95% CI 1.65-4.17). Mortality rates were significantly lower in patients with EOSS stages 0 and 1 (HR 0.62, 95% CI 0.42-0.92) and higher in patients with BMI class III (HR 1.58, 95% CI 1.03-2.42). In patients with a BMI ≥ 25 kg/m2, the risk for intubation increased with progressive EOSS stages. Only individuals in BMI class III showed an increased risk for intubation (HR 2.24, 95% CI 1.50-3.34). Mortality risk was increased in EOSS stages 2 and 4 compared to EOSS 0 and 1, and in patients with BMI class II and III, compared to patients with overweight. CONCLUSIONS: EOSS was associated with adverse COVID-19 outcomes, and it distinguished risks beyond BMI. Patients with overweight and obesity in EOSS stages 0 and 1 had a lower risk than patients with normal weight. BMI does not adequately reflect adipose tissue-associated disease, it is not ideal for guiding chronic-disease management.


Asunto(s)
COVID-19 , Obesidad , Adulto , Anciano , COVID-19/complicaciones , COVID-19/epidemiología , COVID-19/mortalidad , Comorbilidad , Femenino , Hospitalización , Humanos , Masculino , Persona de Mediana Edad , Obesidad/complicaciones , Obesidad/epidemiología , Obesidad/fisiopatología , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
3.
Biol Methods Protoc ; 8(1): bpad009, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37351376

RESUMEN

Throughout the entire coronavirus disease 19 (COVID-19) pandemic, there were disruptions in the supply chain of test materials around the world, primarily in poor- and middle-income countries. The use of 3D prints is an alternative to address swab supply shortages. In this study, the feasibility of the clinical use of 3D-printed swabs for oropharyngeal and nasopharyngeal sampling for the detection of SARS-CoV-2 infection was evaluated. For that purpose, paired samples with the 3D printed and the control swabs were taken from 42 adult patients and 10 pediatric patients, and the results obtained in the detection of SARS-CoV-2 by reverse transcription and quantitative polymerase chain reaction (RT-qPCR) were compared. Additionally, in those cases where the result was positive for SARS-CoV-2, the viral load was calculated by means of a mathematical algorithm proposed by us. For both adults and children, satisfactory results were obtained in the detection of SARS-CoV-2 by RT-qPCR; no significant differences were found in the quantification cycle values between the 3D-printed swab samples and the control samples. Furthermore, we corroborated that the 3D-printed swabs caused less discomfort and pain at the time of sampling. In conclusion, this study shows the feasibility of routinely using 3D-printed swabs for both adults and children. In this way, it is possible to maintain local and cheaper consumption along with fewer distribution difficulties.

4.
Head Neck ; 44(12): 2803-2809, 2022 12.
Artículo en Inglés | MEDLINE | ID: mdl-36129095

RESUMEN

OBJECTIVE: Present the feasibility, applicability, clinical effectiveness, and results of complicated Shamblin II or III carotid body tumors treated with a two-stage hybrid surgical approach. MATERIALS AND METHODS: Retrospective, observational, cross-sectional, descriptive study of the successful treatment of 16 cases of difficult Shamblin II or III carotid body tumors, consisting of a two-stage surgical approach. We conducted a retrospective, observational, cross-sectional, descriptive study of a series of patients with complicated Shamblin II or III carotid body tumors, which we treated with a two-stage hybrid surgical procedure, in which we first placed a carotid endoprosthesis and 45 days later performed surgical resection of the tumor, following our originally published technique. This study was conducted from February, 2007 to November, 2019, in a third level care centre. RESULTS: We treated 16 patients with a mean age of 50.5 years. All resided at more than 2000 meters above sea level. In all 16 a complete resection was performed. The average duration of surgery was 103.9 min, the average intraoperative bleeding was 69 ml. There were three cases of neuropraxia. The ansa cervicalis nerve had to be sectioned in three cases and there was permanent upper laryngeal nerve injury in two cases. There were no permanent cerebrovascular injuries from placement of the endoprostheses. One patient developed transient cerebral ischaemia (TIA) with no long-term sequelae. There were two cases of asymptomatic late occlusion of the endoprostheses. The average initial volume of the tumors was 54.4 cc. The average tumor volume 35 days after implant of the endoprosthesis was 30.9 cc. SYMPTOMS: Presence of tumors in the neck in all cases and two cases of dysphagia. CONCLUSION: This two-stage hybrid technique allowed for the complete resection of difficult Shamblin II or III carotid body tumors, with one case of TIA and two with permanent upper laryngeal nerve injuries and without mortality.


Asunto(s)
Tumor del Cuerpo Carotídeo , Ataque Isquémico Transitorio , Humanos , Persona de Mediana Edad , Tumor del Cuerpo Carotídeo/diagnóstico por imagen , Tumor del Cuerpo Carotídeo/cirugía , Tumor del Cuerpo Carotídeo/complicaciones , Estudios Retrospectivos , Estudios Transversales , Ataque Isquémico Transitorio/complicaciones , Procedimientos Quirúrgicos Vasculares/efectos adversos , Resultado del Tratamiento
5.
Crit Care Explor ; 4(4): e0670, 2022 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-35372845

RESUMEN

A proof-of-concept study using thrombolysis with catheter-directed tissue plasminogen activator (tPA) and pulmonary angiography imaging was performed to visualize perfusion deficits and reperfusion/therapeutic effects of tPA. DESIGN: A prospective, open-label, compassionate study. Descriptive statistics were presented for categorical variables and as means with sds for continuous variables. The Wilcoxon test was used to determine the differences between the two-related samples and a t test for continuous variables. Statistical significance was set at p value of less than 0.05. Agreement between observations was evaluated using the Kappa Cohen index and overall agreement using the Fleiss Kappa coefficient. SETTING: A single COVID-19 ICU of Mexico´s General Hospital Dr Eduardo Liceaga. SUBJECTS: Fifteen patients with severe Delta variant severe acute respiratory syndrome coronavirus 2 infection, 18-75 years old, requiring mechanical ventilation with a persistent Fio2 requirement of 70% or higher and Pao2/Fio2 ratio (or imputed ratio) less than 150 for more than 4 hours. The coagulation inclusion criteria were International Society on Thrombosis and Haemostasis score greater than 5, and presence of a d-dimer greater than 1,200, with viscoelastic testing using rotational thromboelastometry (Instrumentation Laboratories, Mexico City, Mexico) showing both hypercoagulability (EXTEM amplitude at 5 min > 65 FIBTEM > 30) and hypofibrinolysis (EXTEM maximum lysis < 8%). INTERVENTIONS: Catheter-directed tPA angiography and iFlow system analysis to assess pre-tPA baseline pulmonary perfusion and changes in response to thrombolysis. RESULTS: Nine patients had microvascular filling defects demonstrated by angiography, and good agreement was found with iFlow analysis (ƙ = 0.714). Statistically significant differences were identified in the area under the curve (AUC) region of interest/AUC reference tissue with and without filling defects in phase 2 DM -0.09206 (sd ± 0.16684) (p = 0.003). The Pao2/Fio2 values measured immediately and 48 hours after the procedure were significantly higher (p = 0.001 and p = 0.005, respectively). Statistically significant differences were found in d-dimer values (p = 0.007), Fio2 (p = 0.002), and oxygen saturation in arterial blood/Fio2 (p = 0.045), as well as in the number of patients who required prone positioning before, immediately after the procedure, and at 48 hours after the procedure (p = 0.002). CONCLUSIONS: Thrombolysis with catheter-directed tPA resulted in imaging evidence via pulmonary angiography and iFlow technology of improved lung perfusion in COVID-19 patients with severe respiratory failure.

6.
Radiol Case Rep ; 17(4): 1266-1270, 2022 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-35198090

RESUMEN

Scrotal arteriovenous malformations (AVM) are extremely rare, making them difficult and complex to diagnose, and a therapeutic challenge; few cases of this type have been reported in the literature. This article reports the case of a male patient, 12 years old, with congenital AVM and background of treatment with sclerotherapy and embolization: it was decided to perform a surgical resection, which was successful. Angiography is obligatory in arteriolar cases, and it was backed up with surgical AVM treatment, taking into account the great importance of pre-surgical embolization.

7.
Radiol Case Rep ; 16(11): 3534-3539, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-34584592

RESUMEN

We present the case of a 12-year-old girl with a history of vascular anomalies in the lower pelvic limbs and back, who developed unilateral deep vein thrombosis of the left lower limb after her pubertal development, she was diagnosed with May-Thurner syndrome with an abnormal venous drainage of the pelvic structures through the superior hemorrhoidal veins to the inferior mesenteric vein towards the porta system, this being a chronic manifestation. This kind of behavior has not been documented in the reviewed medical literature. Secondarily, balloon angioplasty was performed without breaking the stenotic ring. As a second attempt, it was decided to place the venous stent, with satisfactory resolution of the symptoms. There are controversies about the indications for the use of anticoagulants and antiplatelet agents, or the indications to place a venous stent in children. We must consider an approach to for effective therapeutic treatment in these cases is to control bleeding, the main goal being trying to avoid ulcerations in the lower limb due to venous insufficiency with irreversible affectation of the valvular system.

8.
Microorganisms ; 8(10)2020 Oct 10.
Artículo en Inglés | MEDLINE | ID: mdl-33050487

RESUMEN

There is a deep need for mortality predictors that allow clinicians to quickly triage patients with severe coronavirus disease 2019 (Covid-19) into intensive care units at the time of hospital admission. Thus, we examined the efficacy of the lymphocyte-to-neutrophil ratio (LNR) and neutrophil-to-monocyte ratio (NMR) as predictors of in-hospital death at admission in patients with severe Covid-19. A total of 54 Mexican adult patients with Covid-19 that met hospitalization criteria were retrospectively enrolled, followed-up daily until hospital discharge or death, and then assigned to survival or non-survival groups. Clinical, demographic, and laboratory parameters were recorded at admission. A total of 20 patients with severe Covid-19 died, and 75% of them were men older than 62.90 ± 14.18 years on average. Type 2 diabetes, hypertension, and coronary heart disease were more prevalent in non-survivors. As compared to survivors, LNR was significantly fourfold decreased while NMR was twofold increased. LNR ≤ 0.088 predicted in-hospital mortality with a sensitivity of 85.00% and a specificity of 74.19%. NMR ≥ 17.75 was a better independent risk factor for mortality with a sensitivity of 89.47% and a specificity of 80.00%. This study demonstrates for the first time that NMR and LNR are accurate predictors of in-hospital mortality at admission in patients with severe Covid-19.

9.
Pediatr Hematol Oncol ; 24(6): 403-8, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17710657

RESUMEN

UNLABELLED: Amifostine has emerged as a pancytoprotectant shown protection against nephrotoxicity, neurotoxicity and ototoxicity in preclinical studies. METHODS: We designed a prospective comparative randomized trial to evaluate the cytoprotective effects of amifostine in patients with osteosarcoma receiving cisplatin and doxorrubicin. Patients were evaluated for renal, hearing and cardiac toxicity. RESULTS: We included 28 patients, mean age was 11.6 years, five had metastatic disease. Fifteen patients received amifostine and 13 did not. 20% of patients receiving amifostine developed renal toxicity compared to 30% in the control group (p = 0.318). Grade 1 and 2 audiologic toxicity was present in 100% of the experimental group against 85% of the controls (p = 0.501). Grade 1 cardiac toxicity was present in 2 patients in the control group (p = 0.175). There were no statistical significant differences between the two groups for chemotherapy-related toxicity. Response to chemotherapy was significantly better in the amifostine group. CONCLUSION: amifostine did not reduce the ototoxicity and nephrotoxicity of our treatment regime. It was not well tolerated due to emesis. It is a selective cytoprotectant without reducing the effect of chemotherapy.


Asunto(s)
Amifostina/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Neoplasias Óseas/tratamiento farmacológico , Pérdida Auditiva/prevención & control , Cardiopatías/prevención & control , Enfermedades Renales/prevención & control , Osteosarcoma/tratamiento farmacológico , Adolescente , Amifostina/efectos adversos , Antieméticos/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Gluconato de Calcio/uso terapéutico , Niño , Cisplatino/administración & dosificación , Doxorrubicina/administración & dosificación , Doxorrubicina/efectos adversos , Femenino , Pérdida Auditiva/inducido químicamente , Cardiopatías/inducido químicamente , Humanos , Hipocalcemia/tratamiento farmacológico , Hipocalcemia/prevención & control , Infusiones Intraarteriales , Infusiones Intravenosas , Enfermedades Renales/inducido químicamente , Masculino , Terapia Neoadyuvante , Ondansetrón/uso terapéutico , Osteosarcoma/secundario , Estudios Prospectivos , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Vómitos/inducido químicamente , Vómitos/prevención & control
13.
An. otorrinolaringol. mex ; 46(1): 12-15, dic.-feb. 2001. ilus
Artículo en Español | LILACS | ID: lil-312352

RESUMEN

El objetivo del reporte es demostrar angiográficamente las características de las anomalías vasculares auriculares para poderlas clasificar de acuerdo a los hallazgos con base en los criterios descritos por Mullicken y Glowacki en hemangiomas, malformación arteriovenosa de alto flujo (MAV alto flujo) y MAV bajo flujo. El tratamiento propuesto para las diferentes anomalías vasculares depende del tipo de que se trate. Las MAV de alto flujo, deberán manejarse con embolización prequirúrgica y cirugía radical cuando sea posible para retirar nido malformativo y tejido redundante, evitando de esta forma el sangrado. Dentro de una serie de 85 pacientes con anomalías vasculares de cabeza y cuello, únicamente 3 fueron clasificados como MAV de alto flujo en territorio auricular.


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Anomalías Congénitas , Cartílago Auricular , Embolización Terapéutica , Hemangioma
14.
Rev. mex. radiol ; 51(3): 109-13, jul.-sept. 1997. tab, ilus
Artículo en Español | LILACS | ID: lil-225104

RESUMEN

Los autores presentan su experiencia inicial en el tratamiento de las estenosis benignas de las vías biliares (EBVB, obtenida en un grupo de 21 pacientes, 15 de los cuales fueron consecutivos a colecistectomía abierta, convencional y seis a colecistectomía laparoscópica. En tres pacientes se colocó una prótesis metálica de Palmaz. En los 18 restantes, se colocaron férulas de teflón de calibre 9.5 Fr. que se cambiaron cada tres meses por calibres progresivos de los números 12,14 16 y 18 Fr. estos últimos de PVC. A los 18 meses se retiró toda instrumentación y se puso a los pacientes en observación. A la fecha la férula ha sido retirada en cuatro que están asintomáticos y en los restantes continuamos en proceso de recambio con buenos resultados clínicos y radiológicos. Los resultados iniciales hacen considerar que este método constituye una alternativa viable sobre la que buscamos tener mas experiencia


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Colecistectomía/efectos adversos , Catéteres de Permanencia , Enfermedades de las Vías Biliares , Radiología Intervencionista/métodos
15.
Rev. mex. radiol ; 51(3): 123-8, jul.-sept. 1997. tab, ilus
Artículo en Español | LILACS | ID: lil-225107

RESUMEN

Desde el inicio de la Radiologúia Intervencionista como una rama terapéutica de la Radiología, se implementaron sustancias capaces de ocluir vasos anormales. Los agentes embolígenos existentes se pueden clasificar de acuerdo al tiempo de embolización, a su composición y por último a su aplicación clínica. Dentro de los materiales embolizantes temporales, el más utilizado en el Gelphoam* (esponja de gelatina absorbible) que tiene como ventajas ser accesible en cuanto a disponibilidad y costo. Sin embargo tiene la desventaja de que es aplicable únicamente a vasos de mediano y gran calibre y que es un material temporal para ser absorbible en un máximo de 21 días. Este informe, presentamos nuestra experiencia en el Hospital General de México con una pasta no absorbible, la cual esta compuesta de Gelphoam, fleboesclerosante y medio de contraste. La finalidad de la adición del fleboesclerosante es producrir un efecto permanente. Esta pasta se fragmenta de forma que se consigue un material embolizante que puede aplicarse en vasos de pequeño y mediano calibre, sin alcanzar la circulación capilar. La cual hemos utilizado en diferentes procedimientos y presentamos la forma como se prepara esta pasta y describimos los casos en que ha sido utilizada y en que tipo de patologías ha corroborado su eficacia, con estudios de control


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Enfermedades Vasculares/terapia , Materiales Biocompatibles/uso terapéutico , Embolización Terapéutica/métodos , Radiología Intervencionista/métodos
16.
Rev. mex. radiol ; 52(3): 105-7, jul.-sept. 1998. ilus
Artículo en Español | LILACS | ID: lil-241426

RESUMEN

Desde 1981, en que por primera vez se describió el Síndrome de Inmunodeficiencia Adquirida, se ha informado más de cinco millones de casos de este padecimiento con una tasa de mortalidad superior a 50 por ciento. Se conoce el predominio en la población homosexual y sus frecuentes complicaciones. Dentro de las complicaciones neoplásicas, el sarcoma de Kaposi epidémico ocupa un lugar importante, sobre todo en sus presentaciones en piel y tórax. Se conoce que el tercer sitio de afección es el tubo digestivo, sin embargo poco se ha escrito acerca de esta presentación. Este informe es el resultado de un estudio retrospectivo realizado en el Hospital General de México, en el Servicio de Gastroenterología, tanto en los Departamentos de Endoscopia como de radiología e Imagen, donde se revisaron 26,000 estudios baritados del esófago, estómago y duodeno y 16,216 endoscopias, efectuadas en el lapso comprendido de enero de 1986 a diciembre de 1995. Se obtuvieron cinco resultados positivos para de Kaposi en tubo digestivo, uno en esófago y cuatro en estómago. Se descubren los caracteres morfológicos y epidemiológicos


Asunto(s)
Humanos , Masculino , Adolescente , Adulto , Persona de Mediana Edad , Sarcoma de Kaposi/diagnóstico , Sarcoma de Kaposi/inmunología , Sarcoma de Kaposi/epidemiología , Neoplasias Gástricas , Biopsia , Estudios Retrospectivos , Endoscopía del Sistema Digestivo , Síndrome de Inmunodeficiencia Adquirida/complicaciones , Síndrome de Inmunodeficiencia Adquirida/diagnóstico , Síndrome de Inmunodeficiencia Adquirida/patología
17.
Rev. mex. radiol ; 50(3): 93-8, jul.-sept. 1996. tab, ilus
Artículo en Español | LILACS | ID: lil-184157

RESUMEN

Las anomalías vasculares constituyen una de las alteraciones congénitas más frecuentes. La clasificación biológica ha facilitado su entendimiento, ya que lesiones similares en apariencia externa pueden tener patrones de crecimiento diferentes y contrariamente, lesiones biológicamente idénticas pueden diferir en apariencia externa debido a la profundidad de su localización. En el presente informe, proponemos a la angiografía como método diagnóstico y la embolización como alternativa de tratamiento en aquellas anomalías con componente arterial, demostrando que es un método idóneo obteniendo una adecuada respuesta con mínima morbilidad. Durante un período de ocho meses; 25 niños de ocho meses a 18 años fueron estudiados por anomalías vasculares. Se clasificaron por examen físico y angiografía diagnóstica y se excluyeron dos pacientes. Resultaron 13 hemangiomas y 10 malformaciones vasculares. De los 23 pacientes estudiados, 19 se sometieron a embolización arterial superselectiva y cuatro no se embolizaron por no demostrarse aporte arterial. Todos los niños presentaron una respuesta buena o excelente con mínima morbilidad


Asunto(s)
Humanos , Masculino , Femenino , Recién Nacido , Lactante , Preescolar , Adolescente , Arterias/anomalías , Angiografía , Enfermedades Cutáneas Vasculares/congénito , Enfermedades Cutáneas Vasculares/terapia , Cara/anomalías , Hemangioma/terapia , Embolización Terapéutica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA